Health
Psilocybin could be a promising therapeutic strategy for people with treatment-resistant depression
Psilocybin could be a promising therapeutic strategy for people with treatment-resistant depression
Researchers at Trinity College Dublin have participated in the largest and most rigorous clinical trial to date of psilocybin (a psychoactive ingredient in magic mushrooms), pointing to the possibility that COMP360 psilocybin with psychological support could be a beneficial therapeutic strategy for people with treatment-resistant depression (TRD).